Search

Issue
Title
Authors
Variant of development of comorbid condition with late diagnosis of pancreatogenic diabetes mellitus: clinical case
Kudinova E.V., Davidenko I.Y., Volkova N.I.
Evaluation of non-glycemic effects of a fixed combination of alogliptin and pioglitazone
Elsukova O.S., Nikitina E.A.
Analysis of the prognostic quality of mortality predictors in patients with COVID-19 and comorbid background: a retrospective study
Aramisova L.S., Zhurtova I.B., Khachmakhova E.Z.
Possibilities of using a fixed combination of alogliptin and pioglitazone in patients with type 2 diabetes mellitus in everyday clinical practice
Elsukova O.S., Nikitina E.A., Chuprova A.V., Kaysina O.A.
Modern and safe treatment of type 2 diabetes mellitus. Clinical case of the use of gozogliptin in the treatment of a patient with decompensated diabetes mellitus
Smirnova E.Y.
Pharmacotherapeutic aspects of gestational diabetes mellitus against the background of impaired maternal immunity
Kazimova A.U., Polukhova S.M.
Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination
Biryukova E.V., Shinkin M.V., Morozova I.A.
Vildagliptin - new opportunities in the treatment of type 2 diabetes mellitus
Pavlova M.G.
P-cell dysfunction in type 2 diabetes mellitus: the possibilities of modern antihyperglycemic therapy
Chernikova N.A.
New possibilities of using the FreeStyle Libre Flash-glucose monitoring system. FreeStyle Libre software ecosystem in Russia
Demidov N.A.
The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine
Kochetkov A.I., Pereverzev A.P., Ostroumova O.D., Gusenbekova D.G., Romanovsky R.R., Shatalova N.A.
Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study
Mkrtumyan A.M., Vorobyev S.V., Volkova A.R., Vorokhobina N.V.
Statins and the risk of diabetes: an evidence-based review
Leonova M.V.
Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia
Pereverzev A.P., Ostroumova O.D., Tkacheva O.N.
Genetic predictors of the pharmacological effects of dipeptidyl peptidase-4 inhibitors and sulfonylureas in patients with type 2 diabetes mellitus
Shorokhova P.B., Baranov V.L., Vorokhobina N.V., Shpilevaya O.S.
Potentials for the management of cardiovascular risk in diabetic patients on insulin therapy
Galstyan G.R., Antsiferov M.B., Alekseeva Y.G.
Advantages of switch to premixed insulin degludec/aspart in patients with type 2 diabetes mellitus who have not achieved an optimal control with previous insulin therapy
Elsukova O.S., Sobolev A.A.
POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY
Statsenko M.E., Turkina S.V., Tyshchenko I.A., Fabritskaya S.V., Poletaeva L.V.
EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE
Demidov N.A., Antsiferov M.B., Dorofeeva L.G.
Metabolic syndrome and intestinal microbiota
Egshatyan L.V., Mkrtumyan A.M., Zvenigorodskaya L.A.
APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS
Antsiferov M.B.
Gipoglikemiya i kachestvo zhizni bol'nykh sakharnym diabetom 2 tipa
Antsiferov M.B., Nikitina T.P., Rodionova A.Y., Kurbatova K.A., Ionova T.I.
Effektivnost' trekhkomponentnoy terapii s ispol'zovaniem liraglutida (Viktoza) -pervogo analoga glyukagonopodobnogo peptida-1 dlitel'nogo deystviya - u patsientov s sakharnym diabetom 2 tipa i vistseral'nym ozhireniem
Antsiferov M.B., Koteshkova O.M.
Primenenie Aktovegina kak universal'nyy metod lecheniya oslozhneniy sakharnogo diabeta
Meleshkevich T.A., Luchina E.I., Lukashova M.E.
Fiksirovannaya kombinatsiya saksagliptina i metformina modifitsirovannogo vysvobozhdeniya - novyy shag v uluchshenii priverzhennosti k lecheniyu sakharnogo diabeta 2 tipa
Biryukova E.V.
KLINIKA, DIAGNOSTIKA I LEChENIE DIABETIChESKOY NEYROPATII
Sharonova L.A., Verbovoy A.F., Sharonova D.Y.
Novyy klass antidiabeticheskikh preparatov - ingibitory natriy-glyukoznykh kotransporterov
Ushkalova E.A.
PERSPEKTIVNYE STRATEGII V LEChENII DIABETIChESKOY POLINEVROPATII: ROL' ANTIOKSIDANTNOY TERAPII
Gur'eva I.V., Svetlova O.V.
O RATsIONAL'NOM VYBORE FARMAKOTERAPII PRI SAKhARNOM DIABETE 2 TIPA
Biryukova E.V.
APPLICATION OF VILDAGLIPTIN IN COMBINATION WITH INSULIN IN TYPE 2 DIABETES MELLITUS
Antsiferov M.B., Antsiferov M.B.
Insulin pump - advanced menu of experienced user
Arbatskaya N.Y., Arbatsraya N.Y.
CLINICAL AND METABOLIC EFFICIENCY OF DRUG DIBIKOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Severina T.I., Popkova E.N., Trel'skaya N.Y., Emel'yanov V.V., Severina T.I., Popkova Y.N., Trelskaya N.Y., Yemelyanov V.V.
COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N.A., Trukhina L.V., Petunina N.A., Truhina L.V.
ROLE OF SPECIALIZED NUTRITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL EXPERIENCE OF USING OF GLUCERNA SR
Antsiferov M.B., Morgunov L.Y., Antsiferov M.B., Morgunov L.Y.
ADIPONECTIN AND C-REACTIVE PROTEIN AS FACTORS OF CARDIOVASCULAR RISK IN MEN WITH TYPE 2 DIABETES MELLITUS
Morkovskikh N., Morkovskikh N.V.
Advance - movement forward
Petunina N.A., Petunina N.
Efficacy of gosogliptin in the treatment of type 2 diabetes mellitus: a clinical case
Smirnova E.Y.
Efficacy and safety of the Russian GLP-1 receptor agonist Quincenta (semaglutide) in patients with type 2 diabetes mellitus in real clinical practice (QUINPROMIS study. Interim data)
Antsiferov M.B., Koteshkova O.M., Antsiferova D.M., Romashkina L.P., Golubeva Y.V.
Intestinal microbiota status in patients with type 2 diabetes mellitus depending on the presence of chronic pyelonephritis at pre-dialysis stages of chronic kidney disease – an observational case-control study
Sturov N.V., Popov S.V., Kobalava Z.D., Belikov I.I., Zhukov V.A., Lyapunova T.V., Meleshkevich T.A.
Modern aspects of detection and monitoring of preclinical stages of type 1 diabetes mellitus in children
Varlamova T.V., Vezikova N.N.
Cohort study of clinical and anamnestic characteristics of patients with a combination of type 2 diabetes mellitus and irritable bowel syndrome
Suprun O.E., Bagriy A.E., Mikhailichenko E.S., Andreeva E.A., Evtushenko A.A., Suprun E.V.
Intensification of glucose-lowering therapy for type 2 diabetes mellitus using insulin degludec: clinical case analysis
Elsukova O.S.
Modern possibilities for assessing glycemia in diabetic patients
Chernikova N.A., Degtyareva E.I.
Possibilities of using trimetazidine in comorbid cardiovascular pathology and metabolic disorders
Nikiforov V.S.
Features of the pathogenesis and treatment of diabetes mellitus during the COVID-19 pandemic
Bagriy A.E., Mikhailichenko E.S., Prikolota A.V., Mogilevskaya K.E.
Problem of treatment adherence in patients with type 2 diabetes mellitus
Akulova A.D., Zhulina Y.S., Rozhkova V.V., Martynova E.Y., Poteshkin Y.E.
Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus
Antsiferov M.B., Koteshkova O.M., Novikova M.S., Demidov N.A.
What should the practitioner remember when managing patients with diabetic neuropathy
Isakova E.V., Kotov S.V.
Combination of two hypoglycemic drugs for type 2 diabetes mellitus
Morgunova T.B., Fadeyev V.V.
Does autoimmune thyroiditis affect the clinical course of type 1 diabetes mellitus in children, regardless of the functional state of the thyroid gland?
Abdullaev A.N., Litvinova D.V., Rozhkov N.I., Kiyaev A.V.
Hypoglycemic drugs and drug-induced heart failure
Ostroumova O.D., Goloborodova I.V.
Prevention of blindness in diabetes mellitus. From retinal laser coagulation to pharmacology
Shadrichev F.E., Demidova T.Y., Grigorieva N.N., Kozhevnikov A.A.
Poststroke recovery in patients with type 2 diabetes mellitus
Tanashyan M.M., Maksimova M.Y., Antonova K.V., Raskurazhev A.A., Shakhparonova N.V., Romantsova T.I.
ASSESSMENT OF THE EFFICACY AND SAFETY OF INSULIN DEGLUDEC IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS IN REAL-LIFE CLINICAL PRACTICE
Kiyaev A.V., Kondrashova O.E., Chernykh L.G., Pollyak O.Y., Yusupova A.R., Slovak M.A., Zaykova I.O.
Effect of SGLT-2 inhibitors on cardiovascular outcomes: review of results of CVD-REAL trial
Antsiferov M.B.
THE USE OF ANTIBACTERIAL DRUGS DURING ORTHOPAEDIC ALIGNMENT WITH REMOVABLE LAMINAR DENTURES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TAKING INTO ACCOUNT THE RESULTS OF PCR-BASED DIAGNOSTICS
Shevkunova N.A.
SAFE AND EFFECTIVE COMBINATION OF ULTRALONG-ACTING BASAL INSULIN DEGLUDEC AND ULTRA-SHORT ACTING INSULINE ASPART IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
Girsh Y.V., Veliyeva O.A.
Current approaches to therapy of type 2 diabetes mellitus in the era of new data on cardiovascular safety
Antsiferov M.B., Schernthaner G.
DIABETIC ANGIOPATHY «PAINFUL» POINTS: FOCUS ON HYPERTRIGLYCERIDEMIA AND FENOFIBRATE POTENTIAL
Rujatkina L.A., Rujatkin D.S., Zemljanuhina S.A.
10 let ispol'zovaniya pompovoy insulinoterapii v moskovskoy pediatricheskoy praktike -
Rybkina I.G., Petryaykina E.E., Koltunov I.E.
Preimushchestva fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysvobozhdeniya (Kombogliz Prolong) v terapii SD 2 tipa
Ametov A.S.
Statiny i risk vozniknoveniya novykh sluchaev sakharnogo diabeta: sootnoshenie riska i pol'zy. Sovremennye predstavleniya o tselevykh urovnyakh lipidov u patsientov s sakharnym diabetom
Shalaev S.V., Safiullina Z.M., Mikhal'chuk N.A.
PATOGENETIChESKIE PODKhODY K TERAPII DIABETIChESKOY POLINEVROPATII
Badalyan O.L., Savenkov A.A.
Osobennosti terapii perenesennogo insul'ta u bol'nykh sakharnym diabetom
Shavlovskaya O.A.
Rol' i mesto gipoglikemii v upravlenii sakharnym diabetom 2 tipa
Chernikova N.A., Antsiferov M.B.
SAKhARNYY DIABET 2 TIPA I NEALKOGOL'NAYa ZhIROVAYa BOLEZN' PEChENI: PRAKTIChESKIE REKOMENDATsII DLYa ENDOKRINOLOGOV
Ametov A.S.
Vybor gliptinov v raznykh klinicheskikh situatsiyakh - kommentarii k portretam patsientov
Ruyatkina L.A., Sorokin M.Y.
TYPE 2 DIABETES MELLITUS AND CONCOMITANT DISEASES: ADVANTAGES OF USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR SAXAGLIPTIN (ONGLYZA ®)
Antsiferov M.B., Petunina N.A., Antsiferov M.B., Petunina N.A.
Galvus and Galvus Met in treatment of elderly patients with type 2 diabetes mellitu
Antsiferov M.B., Antciferov M.B.
DIABETIC AUTONOMIC NEUROPATHY AND DIGESTIVE ORGANS
Pogromov A.P., Baturova V.Y., Pogromov A.P., Yu Baturova V.
INITIATION OF THERAPY WITH INSULIN PUMP IN PATIENTS WITH TYPE 1 DIABETES
Antsiferov M.B., Koteshkova O.M., Kleymenova S.A., Antsiferov M.B., Koteshkova O.M., Kleimenko S.A.
WHEN TO BEGIN COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N.A., Petunina N.A.
ANTIOXIDANT THERAPY OF DIABETIC POLYNEUROPATHY
Tabeeva G.R., Azimova Y.E., Tabeeva G., Azimova Y.
Sulfonylurea drugs and risk of cardiovascular complications - much ado about nothing?
Nedosugova L.V., Nedosugova L.
The effectiveness of the drug Vessel Due F in patients with diabetes with nonproliferative and preproliferative diabetic retinopathy
Ishchenko I.M., Milen'kaya T.M., Ischenko I.M., Milenkaya T.M.
Clinical cases of management of patients with type 2 diabetes mellitus using GLP-1 receptor agonists
Kanavets N.S., Rebrova D.V.
Current trends in self-monitoring of glycemic levels
Koteshkova O.M., Antsiferov M.B., Antsiferova D.M.
The impact of disease duration and glycemic control of type 1 diabetes mellitus on the lipid profile and intima-media thickness in children
Sadykova D.I., Shaydullina M.R., Aksenova A.A., Galimova L.F.
Screening, diagnosis and treatment of early carbohydrate metabolism disorders
Demidova I.Y., Boeva V.V.
Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection
Zhurtova I.B., Gubachikova A.M., Aramisova L.S., Anaeva L.A., Abdul Moati H.A.
How to improve the quality of type 2 diabetes mellitus management in routine clinical practice. experience of using a glycemic variability diary
Astamirova K.S., Gatina A.I., Gorbunova Y.S., Demidov N.A., Ivanenko T.S., Kolesnikova M.I., Lapteva O.A., Morozova I.V., Parshina V.A., Presnyakova O.Y., Smirnova E.Y., Smirnova N.P., Startseva M.A., Khamrazhanov Z.A., Kholmskaya N.I.
Glycemic variability diary as a tool for assessing the effectiveness of diabetes therapy. Clear and accessible. Case series
Smirnova E.Y.
Modern possibilities for correcting the uric acid level and eliminating skin manifestations of gout
Vereshchagin E.I., Svechnikova E.V., Artemyeva N.O.
Multiple thyroid carcinoma and other long-term endocrine consequences of chemoradiotherapy for medulloblastoma: a clinical case
Khruleva Y.I., Amergulov I.I., Likhodey N.V., Dzyuba A.S., Sych Y.P., Pavlova M.G.
Dermatoses in elderly diabetic patients
Ladygina D.O., Zheleznyakova A.V.
Is non-alcoholic fatty liver disease a consequence of obesity and a predictor of diabetes?
Volkova N.I., Panenko S.O., Golubeva A.O.
Testosterone replacement therapy in men with type 2 diabetes mellitus and neuropathy
Zelenina T.A., Salukhov V.V., Zemlyanoy A.B., Chebykina O.E.
The use of fixed ratio combination of insulin glargine and lixisenatide in patients with type 2 diabetes mellitus in real clinical practice. Own clinical experience
Khamnueva L.Y., Andreeva L.S., Davydova A.V., Chugunova E.V., Tokareva N.P., Molodtsova N.Y.
Modern approaches to using the FreeStyle Libre Flash glucose monitoring system
Demidov N.A., Koteshkova O.M., Antsiferov M.B.
Modern approaches to the choice of hypoglycemic therapy in patients with type 2 diabetes mellitus: a niche of DPP-4 inhibitors
Chernikova N.A., Knyshenko O.A.
The state of carbohydrate metabolism and the development of cerebrovascular diseases in patients with type 2 diabetes mellitus
Antonova K.V., Tanashyan M.M., Maksimova M.Y., Shakhparonova N.V., Romantsova T.I.
Application of Cocarnit in complex treatment of patients with diabetic polyneuropathy in outpatient practice
Novikova L.B., Tarkhanova I.Y., Dmitrieva O.E., Fomichev A.V., Kakaulina L.N.
NEW POSSIBILITIES OF CARDIOVASCULAR RISK MANAGEMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Verbovoy A.F., Pashentseva A.V., Verbovaya N.I., Kosareva O.V.
The use of insulin glargine 300 lU/ml (Toujeo SoloStar®) in real clinical practice
Antsiferov M.B.
CURRENT POSSIBILITIES OF COMBINED THERAPY IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Chemikova N.A.
Features of use of dapagliflozin in thetreatment of patients with type 2 diabetes mellitus
Antsiferov M.B.
OVERVIEW OF PHARMACOECONOMIC STUDIES OF INSULIN PUMP THERAPY IN DIABETES MELLITUS
Tolkushin A.G.
Sakharosnizhayushchiy effekt flozinov po sravneniyu s preparatami sul'fonilmocheviny u patsientov s sakharnym diabetom 2 tipa
Galstyan G.R.
Preimushchestva svoevremennoy initsiatsii insulinoterapii. Rezul'taty rossiyskoy observatsionnoy programmy HUBIN
Chernikova N.A., Ivanova L.P., Abaeva F.T.
Primenenie kombinirovannoy terapii glimepiridom i metforminom u patsientov s sakharnym diabetom 2 tipa. Rezul'taty Rossiyskogo observatsionnogo issledovaniya
Zaytseva N.V., Shamkhalova M.S.
101 - 200 of 332 Items << < 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"